Abstract
Cyclopropanols have found an increasing number of uses as synthetic intermediates and as functional groups in the design of enzyme inhibitors. This mini-review will discuss some of the most recent and successful methodologies for the synthesis of these entities, focusing mainly on the stereoselective transformations. The new procedure developed in our group for the preparation of cyclopropanols in chiral form is also reviewed.
Keywords: Cyclopropanols, stereoselective synthesis
Mini-Reviews in Organic Chemistry
Title: Stereoselective Synthesis of Cyclopropanols
Volume: 3 Issue: 4
Author(s): P. Garcia, D. Diez, A. B. Anton, N. M. Garrido, I. S. Marcos, P. Basabe and J. G. Urones
Affiliation:
Keywords: Cyclopropanols, stereoselective synthesis
Abstract: Cyclopropanols have found an increasing number of uses as synthetic intermediates and as functional groups in the design of enzyme inhibitors. This mini-review will discuss some of the most recent and successful methodologies for the synthesis of these entities, focusing mainly on the stereoselective transformations. The new procedure developed in our group for the preparation of cyclopropanols in chiral form is also reviewed.
Export Options
About this article
Cite this article as:
Garcia P., Diez D., Anton B. A., Garrido M. N., Marcos S. I., Basabe P. and Urones G. J., Stereoselective Synthesis of Cyclopropanols, Mini-Reviews in Organic Chemistry 2006; 3 (4) . https://dx.doi.org/10.2174/157019306778742878
DOI https://dx.doi.org/10.2174/157019306778742878 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Aspects of Melatonin Treatment in Tinnitus: A Review
Current Drug Targets Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member:
Current Medicinal Chemistry Diagnostic Issues in Early-Onset Obsessive-Compulsive Disorder and their Treatment Implications
Current Neuropharmacology Pro-inflammatory Mediators and Oxidative Stress: Therapeutic Markers for Recurrent Angina Pectoris after Coronary Artery Stenting in Elderly Patients
Current Vascular Pharmacology Anticancer Actions of Omega-3 Fatty Acids - Current State and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Subject Index to Volume 10
Current Pharmaceutical Design The Renin-Angiotensin System: New Insight into Old Therapies
Current Medicinal Chemistry Interleukin-10: An Important Immunoregulatory Cytokine With Major Impact on Psoriasis
Current Drug Targets - Inflammation & Allergy Genetics in Osteoarthritis
Current Genomics Immunomodulation and Anti-Cancer Activity of Polysaccharide-Protein Complexes
Current Medicinal Chemistry Low-Dose Aspirin-Associated Upper and Mid Gastrointestinal Tract Damage and Gene Polymorphism
Current Pharmaceutical Design The Pharmacological Effects of Novokinin; a Designed Peptide Agonist of the Angiotensin AT<sab>2</sab> Receptor
Current Pharmaceutical Design Measuring T Cell Cytokines in Allergic Upper and Lower Airway Inflammation: Can We Move to the Clinic?
Inflammation & Allergy - Drug Targets (Discontinued) Cholinergic System and Neuroinflammation: Implication in Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry Prostaglandin EP Receptor Subtypes Involved in Regulating HCO3- Secretion from Gastroduodenal Mucosa
Current Pharmaceutical Design Hirudo medicinalis: Avascular Tissues for Clear-Cut Angiogenesis Studies?
Current Pharmaceutical Design Calpain Inhibition: A Therapeutic Strategy Targeting Multiple Disease States
Current Pharmaceutical Design The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic
Current Pharmaceutical Design Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies
Current Clinical Pharmacology